Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Physical Properties of Amines01:26

Physical Properties of Amines

Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intravenous iron isomaltoside (Monofer)-induced hypophosphataemia: a case report.

Hong Kong medical journal = Xianggang yi xue za zhi·2022
Same author

Outcome of acute ischaemic stroke patients after intravenous alteplase in Hospital Universiti Sains Malaysia.

The Medical journal of Malaysia·2021
Same author

Diagnostic dilemma between skull base osteomyelitis and nasopharyngeal carcinoma: a case series.

Hong Kong medical journal = Xianggang yi xue za zhi·2021
Same author

Unusual presentation of appendicitis as soft tissue infection of the thigh.

Journal of surgical case reports·2021
Same author

Immediate unilateral breast reconstruction and contralateral breast augmentation with bilateral free deep inferior epigastric perforator flaps.

Annals of the Royal College of Surgeons of England·2020
Same author

New Service Model for Common Mental Disorders in Hong Kong: a Retrospective Outcome Study.

East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan·2019
Same journal

Transient abnormal myelopoiesis in Down's syndrome neonates.

The American journal of pediatric hematology/oncology·1994
Same journal

Secondary acute promyelocytic leukemia in a child treated with epipodophyllotoxins.

The American journal of pediatric hematology/oncology·1994
Same journal

Maternal malignancy involving the products of conception: a report of malignant melanoma and medulloblastoma.

The American journal of pediatric hematology/oncology·1994
Same journal

Sphenoid sinus involvement in neuroblastoma.

The American journal of pediatric hematology/oncology·1994
Same journal

Transient lupus anticoagulant associated with prothrombin deficiency: unusual cause of bleeding in a 5-year-old girl.

The American journal of pediatric hematology/oncology·1994
Same journal

Disseminated histoplasmosis: a cause of infection-associated hemophagocytic syndrome.

The American journal of pediatric hematology/oncology·1994
See all related articles

Related Experiment Video

Updated: Jun 16, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Anthracycline toxicity.

K Y Wong, B C Lampkin

    The American Journal of Pediatric Hematology/Oncology
    |January 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Anthracycline chemotherapy drugs are vital for cancer treatment but can cause significant toxicities like mucositis and cardiotoxicity. Careful selection of anthracyclines and treatment schedules is crucial to minimize these adverse effects.

    More Related Videos

    A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
    08:09

    A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

    Published on: June 7, 2018

    Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
    04:48

    Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

    Published on: January 7, 2015

    Related Experiment Videos

    Last Updated: Jun 16, 2026

    A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
    05:14

    A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

    Published on: May 16, 2020

    A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
    08:09

    A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

    Published on: June 7, 2018

    Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
    04:48

    Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

    Published on: January 7, 2015

    Area of Science:

    • Oncology
    • Pharmacology
    • Cancer Therapeutics

    Background:

    • Anthracyclines are a cornerstone of cancer chemotherapy.
    • These agents are associated with significant dose-limiting toxicities, including gastrointestinal complications and cardiotoxicity.
    • Potential for toxicity potentiation exists with concurrent radiation or other chemotherapy agents.

    Purpose of the Study:

    • To review the toxicities associated with anthracycline compounds in cancer therapy.
    • To highlight the importance of careful drug selection and scheduling to mitigate adverse events.

    Main Methods:

    • Literature review of anthracycline pharmacology and clinical use.
    • Analysis of reported toxicities and risk factors.
    • Evaluation of strategies for toxicity management.

    Main Results:

    • Common anthracycline toxicities include mucositis, gastrointestinal issues, myelodepression, and cardiotoxicity.
    • Multimodal cancer therapy can exacerbate anthracycline-related adverse effects.
    • Individualized treatment planning is essential.

    Conclusions:

    • Anthracycline therapy requires careful consideration of potential toxicities.
    • Optimizing drug choice, combination, and schedule is key to balancing efficacy and safety.
    • Minimizing anthracycline toxicity is critical for patient outcomes in cancer care.